D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide.
Saved in:
| Title: | D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide. |
|---|---|
| Authors: | McKean WB; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Medical Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Yang J; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA., Boucher K; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Medical Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.; Department of Epidemiology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Shrieve DC; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Suneja G; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Salzman K; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Radiology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Jensen R; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA., Colman H; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA., Cohen AL; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Medical Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.; Division of Oncology, Inova Schar Cancer Institute, Fairfax, Virginia, USA. |
| Source: | Neuro-oncology advances [Neurooncol Adv] 2024 Apr 23; Vol. 6 (1), pp. vdae063. Date of Electronic Publication: 2024 Apr 23 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
